Partial immunity and SARS-CoV-2 mutations-Response

Science. 2021 Apr 23;372(6540):354-355. doi: 10.1126/science.abi6719.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Mutation
  • SARS-CoV-2*
  • Spike Glycoprotein, Coronavirus

Substances

  • Antibodies, Viral
  • Spike Glycoprotein, Coronavirus